Search Results - "Issa GC"

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Authors: Loghavi S Farhat A Jamison TJ et al.

Source: Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1142-1150. Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Case Report: FIA plus venetoclax in a patient on hemodialysis.

Authors: Herstein JE Marx KR Savoy JM et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jan 15; Vol. 15, pp. 1740357. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance.

Authors: Markosian, Christopher Buckley, Conor W. Chai-Ho, Wanxing et al.

Source: Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1845-1848. 4p.

KMT2A alterations in acute myeloid leukemia: a proposed genetic risk model and transplantation outcomes.

Authors: Chen, Li Li, Jianfeng Zhu, Yongmei et al.

Source: Experimental Hematology & Oncology. 10/21/2025, Vol. 14 Issue 1, p1-5. 5p.

This result is not displayed to guests.
Login for full access.

Qingdainone, a novel bioactive compound in Realgar‒Indigo naturalis, induced apoptosis and differentiation in ATRA‐sensitive and ‐resistant acute promyelocytic leukaemia cells.

Authors: Xu, Pengcheng Ou, Yang Tan, Xin et al.

Source: Clinical & Translational Discovery. Jun2026, Vol. 6 Issue 3, p1-13. 13p.

Acute leukemia of ambiguous lineage with KMT2A-alterations in adults.

Authors: Tessier, Steven Greipp, Patricia T. Jevremovic, Dragan et al.

Source: Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 13, p2537-2542. 6p.

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Authors: Short NJ Bataller A DiNardo CD et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled Analysis.

Authors: Haddad FG Jabbour E Sasaki K et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 May; Vol. 26 (5), pp. e678-e682.e1. Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series.

Authors: Marvin-Peek J Sasaki K Kontoyiannis DP et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Aug 01; Vol. 11, pp. 1402897. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition.

Authors: Garcia MB Wang B Sheikh I et al.

Source: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2026 Mar; Vol. 25 (3), pp. 101522. Date of Electronic Publication: 2026 Jan 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib.

Authors: Chien KS Loghavi S Sasaki K et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Feb; Vol. 26 (2), pp. e223-e228.e3. Date of Electronic Publication: 2025 Dec 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis.

Authors: Alhajahjeh, Abdulrahman Beke, Konan E. Grimshaw, Alyssa A. et al.

Source: Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1662-1674. 13p.

Menin inhibitors display differential in vitro sensitivity in KMT2A-rearranged infant acute lymphoblastic leukemia.

Authors: Dymock, Stephen C. C. Oommen, Joyce Malinge, Sebastien et al.

Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1607-1611. 5p.

Novel treatment strategies in acute myeloid leukemia.

Authors: Simkhada S Joshi U Dhakal P

Source: Blood research [Blood Res] 2026 Jun 13; Vol. 61 (1). Date of Electronic Publication: 2026 Jun 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 101605247 Publication Model: Electronic Cited Medium: Print ISSN: 2287-979X (Print) Linking ISSN: 2287979X NLM ISO Abbreviation: Blood Res Subsets: PubMed not MEDLINE

VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial.

Authors: Swaminathan M DiNardo CD Maiti A et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Apr 02; Vol. 15 (1), pp. 52. Date of Electronic Publication: 2025 Apr 02.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.

Authors: Jen WY Marvin-Peek J Kantarjian HM et al.

Source: Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35662. Date of Electronic Publication: 2024 Nov 25.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias.

Authors: Senapati J Konopleva M Issa GC et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Nov 27; Vol. 18 (1), pp. 108. Date of Electronic Publication: 2025 Nov 27.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Chronic renal impairment in patients with chronic myeloid leukemia.

Authors: Abdelhameed, Mohammed R. Abdelhameed, Samir K. Gab, Sahar M.

Source: Egyptian Journal of Haematology. Apr-Jun2026, Vol. 51 Issue 2, p286-291. 6p.

Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.

Authors: van der Noord, Vera E. McLaughlin, Ronan P. Karuntu, Jessica S. et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-18. 18p.